18706 NORTH CREEK PARKWAY, SUITE 104, BOTHELL, WA
Market cap: $27.5M (12/18/2025)
Price: $6.97
Amended material disclosure
Announces Exclusive License to Lasofoxifene Phase 3 Development Program for Metastatic Breast Cancer Candidate and a Financing for up to $236 Million, Investor Presentation
Other Events
Announces Reverse Stock Split
Reports Second Quarter 2025 Financial Results and Provides Business Update
Submission of Matters to a Vote of Security Holders
Reports First Quarter 2025 Financial Results and Pipeline and Business Updates
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Q3
Q2
Q1
FY 2023
Q2 amended
Registration Statement for Securities to be Offered to Employees
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Prospectus filed pursuant to Rule 424(b)(5)
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Amended Schedule 13G - Ownership Report
Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities
Submission Upload
Correspondence